Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by GoldenInvestoron Aug 03, 2021 7:05pm
107 Views
Post# 33646329

RE:RE:RE:Snowball…

RE:RE:RE:Snowball…

Great post!  


Glad that you reminded the board that JRG is not going anywhere.

he is going to focus on strategy & samira willl run the day to day ops!

as he can lead the strategy and remain fully engaged & direct the company.

samira has had the benefit of his leadership and has learned well fron both him and Marc over her time at both companies and will be a star leading the company as per Jonathan's blueprint!

think of it more as working effectively together.  I don't think titles matter so much to them!  I've seen them together and they share the same drive and end result goal!

Other CEO''s that run big ships also have top notch lieutenants that run different big businesses.


Strategy!
 

<< Previous
Bullboard Posts
Next >>